|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 178.75 USD | -1.94% |
|
-3.87% | +94.44% |
| 06-12 | AstraZeneca says Truqap combination approved in US for prostate cancer | AN |
| 06-12 | AstraZeneca Says FDA Approves Truqap Combination for PTEN-Deficient Prostate Cancer | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.41% | +0.14% | +14.46% | +15.94% | +5.43% | +39.53% | +154.43% | +405.60% | +1,432.12% | 1,035B | |
| +1.07% | +3.48% | +7.41% | -0.48% | +16.39% | +53.75% | +50.64% | +46.02% | +105.85% | 574B | |
| +1.32% | +0.22% | +9.56% | +1.05% | -0.33% | +18.35% | +65.35% | +97.31% | +273.33% | 397B | |
| +0.77% | 0.00% | +1.74% | +2.80% | -0.34% | +19.99% | +16.80% | -4.36% | +30.42% | 324B | |
| -1.42% | -1.44% | +5.94% | +2.71% | +13.10% | +45.50% | +8.37% | +56.09% | +109.56% | 298B | |
| +0.44% | +3.48% | +5.33% | +1.03% | +11.39% | +24.48% | +34.39% | +46.52% | +60.10% | 278B | |
| +1.66% | +1.20% | -3.12% | +16.30% | -11.68% | -44.67% | -47.49% | +11.16% | +57.61% | 193B | |
| +0.32% | +1.61% | +5.62% | -3.42% | +8.52% | +19.48% | +63.42% | +46.31% | +129.49% | 191B | |
| -0.22% | -2.76% | -6.93% | -13.51% | +2.32% | +12.08% | +61.30% | +82.62% | +48.72% | 156B | |
| +0.15% | +0.65% | +1.31% | -2.42% | +5.26% | +5.52% | -34.31% | -34.72% | -25.73% | 149B | |
| +0.40% | -0.24% | +1.20% | -3.09% | +5.91% | +12.70% | -11.78% | -15.16% | -21.36% | 116B | |
| -0.03% | -0.43% | -0.75% | -6.94% | -1.86% | -3.29% | +30.63% | +130.51% | +386.31% | 113B | |
| +0.38% | -1.74% | +4.40% | +0.09% | -7.41% | -12.65% | -19.40% | -13.85% | +8.73% | 106B | |
| +1.10% | +2.37% | +4.89% | -2.31% | +8.74% | +28.04% | +44.42% | +13.10% | +12.29% | 105B | |
| +0.30% | -1.38% | -4.41% | -20.99% | -9.62% | -1.31% | +84.00% | +70.17% | +485.85% | 76.18B | |
| +0.97% | +3.17% | -1.66% | -10.29% | +5.11% | +16.16% | +12.83% | +34.48% | +11.62% | 49.55B | |
| +3.21% | +2.99% | -13.58% | -12.31% | -18.60% | -13.13% | +8.48% | -33.54% | +235.95% | 45.85B | |
| +1.12% | +0.08% | -5.85% | -7.51% | -2.22% | +30.09% | -29.19% | -32.32% | -58.88% | 40.52B | |
| +0.20% | +1.29% | -3.30% | +18.19% | +10.96% | +95.54% | +373.73% | +211.70% | -34.67% | 40.24B | |
| Average | +0.24% | +0.96% | +1.17% | -1.33% | +2.16% | +18.22% | +45.61% | +58.82% | +170.91% | 225.68B | |
| Weighted average by Cap. | -0.57% | +1.02% | +6.07% | +3.51% | +5.13% | +26.02% | +61.98% | +130.03% | +428.83% |
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
- Sector AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
